What does Ishara Investments LP hold? Q1 2026 13F Holdings & Portfolio

AI Analysis · Q1 2026 · Q1 2026

Ishara Investments LP filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight

PRAXIS PRECISION MEDICINES I

$14M43K13.1%

AXSOME THERAPEUTICS INC.

$7M41K6.6%

XERIS BIOPHARMA HOLDINGS INC

$6M1.0M5.6%

KALVISTA PHARMACEUTICALS INC

$6M277K5.3%

AMICUS THERAPEUTIC

$5M369K5.1%

BIOMARIN PHARMACEUTICAL INC

$5M82K4.4%

VERASTEM INC

$4M820K4.1%

ULTRAGENYX PHARMACEUTICAL IN

$4M174K3.5%

ARROWHEAD PHARMACEUTICALS IN

$3M55K3.3%

VAXCYTE INC

$3M57K3.2%

Filing history loading…